Insider Buying Report: EyeGate Pharmaceuticals Inc. [EYEG]’s Dir, 10%, Armistice Capital, LLC, Buys 1,531,101 Shares
On Jan. 06, Armistice Capital, LLC invested U.S. $8,000,003 in shares of EyeGate Pharmaceuticals Inc.. The Dir, 10% acquired 1,531,101 shares at a cost per share of $5.22. The transaction increased this specific insider’s holdings to 6,693,202 shares worth around $35.14 million at present. H.C. Wainwright maintained its EyeGate Pharmaceuticals Inc. [EYEG] rating to the […]
